165 related articles for article (PubMed ID: 9160282)
1. Ascorbate availability and neurodegeneration in amyotrophic lateral sclerosis.
Kok AB
Med Hypotheses; 1997 Apr; 48(4):281-96. PubMed ID: 9160282
[TBL] [Abstract][Full Text] [Related]
2. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
3. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
4. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.
Shaw PJ; Eggett CJ
J Neurol; 2000 Mar; 247 Suppl 1():I17-27. PubMed ID: 10795883
[TBL] [Abstract][Full Text] [Related]
5. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
7. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
Walker AK; Farg MA; Bye CR; McLean CA; Horne MK; Atkin JD
Brain; 2010 Jan; 133(Pt 1):105-16. PubMed ID: 19903735
[TBL] [Abstract][Full Text] [Related]
8. Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.
Shan X; Hu JH; Cayabyab FS; Krieger C
Neuroscience; 2005; 134(3):833-46. PubMed ID: 15994023
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
Pasinelli P; Brown RH
Nat Rev Neurosci; 2006 Sep; 7(9):710-23. PubMed ID: 16924260
[TBL] [Abstract][Full Text] [Related]
10. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration.
Li J; Li T; Zhang X; Tang Y; Yang J; Le W
Neurobiol Aging; 2014 Apr; 35(4):837-46. PubMed ID: 24126158
[TBL] [Abstract][Full Text] [Related]
11. The roles of free radicals in amyotrophic lateral sclerosis.
Liu D
J Mol Neurosci; 1996; 7(3):159-67. PubMed ID: 8906612
[TBL] [Abstract][Full Text] [Related]
12. Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons.
Ligon LA; LaMonte BH; Wallace KE; Weber N; Kalb RG; Holzbaur EL
Neuroreport; 2005 Apr; 16(6):533-6. PubMed ID: 15812301
[TBL] [Abstract][Full Text] [Related]
13. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis.
Przedborski S; Donaldson D; Jakowec M; Kish SJ; Guttman M; Rosoklija G; Hays AP
Ann Neurol; 1996 Feb; 39(2):158-65. PubMed ID: 8967746
[TBL] [Abstract][Full Text] [Related]
14. Expression of the low affinity neurotrophin receptor p75 in spinal motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis.
Copray JC; Jaarsma D; Küst BM; Bruggeman RW; Mantingh I; Brouwer N; Boddeke HW
Neuroscience; 2003; 116(3):685-94. PubMed ID: 12573711
[TBL] [Abstract][Full Text] [Related]
15. Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1(G93A) (G1H) transgenic mouse model of amyotrophic lateral sclerosis.
Juan L; Dawei Z; Julie AD
Neurol Res; 2007 Mar; 29(2):204-9. PubMed ID: 17439705
[TBL] [Abstract][Full Text] [Related]
16. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
[TBL] [Abstract][Full Text] [Related]
17. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis.
Durand J; Amendola J; Bories C; Lamotte d'Incamps B
J Physiol Paris; 2006; 99(2-3):211-20. PubMed ID: 16448809
[TBL] [Abstract][Full Text] [Related]
18. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.
Tu PH; Raju P; Robinson KA; Gurney ME; Trojanowski JQ; Lee VM
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3155-60. PubMed ID: 8610185
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis.
Cimini S; Rizzardini M; Biella G; Cantoni L
J Neurochem; 2014 May; 129(3):413-25. PubMed ID: 24359187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
